Home

helps physicians and healthcare professionals

Erectile Dysfunction

helps physicians and healthcare professionals

Doctor123.org

helps physicians and healthcare professionals

Cholangitis, Emergency Medicine


Basics


Description


  • Partial or complete obstruction of the common bile duct owing to gallstones, tumor, cyst, or stricture
  • Increased intraluminal pressure in biliary tree
  • Bacterial multiplication results in bacteremia and sepsis.
  • Purulent infection of biliary tree, which may involve the liver and gallbladder
  • Mirizzi syndrome is defined as common bile duct obstruction owing to extrinsic compression from gallbladder or cystic duct edema or stones.

Etiology


  • Bacterial sources of infection include:
    • Ascending duodenal source
    • Gallbladder infection
    • Portal venous seeding
    • Hematogenous spread with hepatic secretion
    • Lymphatic spread
  • Bacterial organisms include:
    • Anaerobes (Bacteroides and Clostridium species)
    • Intestinal coliform (Escherichia coli)
    • Enterococcus
  • AIDS sclerosing cholangitis characterized by:
    • Papillary stenosis
    • Sclerosing cholangitis
    • Extrahepatic biliary obstruction
    • Cytomegalovirus (CMV), Cryptosporidium, and microsporidia isolated, but causal role not established

Diagnosis


Signs and Symptoms


History
  • Charcot triad:
    • Classic presentation of fever and chills; right upper quadrant (RUQ) pain and jaundice found in only 50-70%
  • Addition of shock and altered mental status denotes a more advanced form of biliary sepsis known as Reynolds pentad.
  • Abdominal pain present in >70%-localizing to RUQ.
  • AIDS sclerosing cholangitis presents with similar symptoms but with more chronic indolent course and near-normal serum bilirubin levels.

Physical Exam
  • Fever found in >90%
  • Peritoneal findings found in 30%
  • Clinically apparent jaundice may be absent in up to 40%.

Essential Workup


  • ECG in patients at risk for coronary artery disease
  • CBC
  • LFT
  • Amylase, lipase
  • Urinalysis
  • Blood cultures
  • Gallbladder US or hepatoiminodiacetic acid (HIDA) scan

Diagnosis Tests & Interpretation


Lab
  • CBC:
    • Leukocytosis with left shift unless immunocompromised or severe sepsis
  • LFTs consistent with cholestasis:
    • Elevated direct bilirubin and alkaline phosphatase
  • Minimal elevation of transaminases (<200 IU/mL)
  • Changes may lag symptom onset by 24-48 hr.
  • Amylase and lipase normal or mildly elevated
  • Urinalysis positive for bilirubin

Imaging
  • US detects the level of ductal obstruction and the presence of gallstone etiology.
  • Radionuclide scanning (HIDA):
    • Indicates obstruction when tracer not found in duodenum within 1 hr
    • More sensitive than US in detecting obstruction in the 1st 24-48 hr before ductal dilation occurs
  • CT scan and CRX:
    • Useful to rule out intestinal obstruction, perforation, or pneumonia
    • 20% gallstones radiopaque
  • Magnetic resonance cholangiopancreatography (MRCP) is highly accurate for biliary obstruction but unnecessary if endoscopic retrograde cholangiopancreatography (ERCP) will be performed.

Diagnostic Procedures/Surgery
Emergency invasive biliary imaging and drainage by ERCP (or surgical/percutaneous if not available), if no response to medical treatment in 12-24 hr  

Differential Diagnosis


  • Acute cholecystitis
  • Hepatitis or hepatic abscess
  • Acute pancreatitis
  • Right pyelonephritis
  • Right lower lobe pneumonia or pulmonary embolism
  • Perforated duodenal ulcer
  • Appendicitis
  • Sepsis with nonspecific elevation of LFTs
  • Fitz-Hugh and Curtis syndrome

Treatment


Pre-Hospital


Stabilize septic shock.  

Initial Stabilization/Therapy


  • Immediate IV fluid resuscitation for dehydration, hemodynamic compromise, and sepsis
  • 80% respond to IV antibiotics within 1st 24 hr
  • Vasopressors (dopamine) for hypotension refractory to volume replacement

Ed Treatment/Procedures


  • Broad-spectrum antibiotics for coliforms, anaerobes, and enterococcus such as:
    • Ampicillin/sulbactam + aminoglycoside (e.g., gentamicin)
    • Imipenem-cilastatin
    • Piperacillin/tazobactam + aminoglycoside (e.g., gentamicin)
    • For penicillin allergy:
      • Adults-use levofloxacin (Levaquin) and metronidazole
      • Pediatrics-use clindamycin and metronidazole
  • Substitute aztreonam for aminoglycoside in renal insufficiency.
  • NPO
  • Nasogastric (NG) suctioning if protracted vomiting or ileus
  • IV fluid (0.9% NS) replacement and maintenance
  • Narcotic analgesia if hemodynamically stable and diagnosis reasonably established
  • Immediate surgical and GI consultation
  • Emergency invasive biliary drainage procedure (surgical, percutaneous, or ERCP) if no response to medical treatment in 12-24 hr

Medication


  • Ampicillin/sulbactam: 3 g (peds: 200 mg/kg/24 h) IV piggyback (IVPB) q6h
  • Aztreonam: 2 g (peds: 120 mg/kg/24 h) IVPB q6h
  • Clindamycin: 600-900 mg (peds: 25-40 mg/kg/24 h) IVPB q6-8h
  • Dopamine: 2-20 μg/min IVPB; titrate to maintain BP
  • Gentamicin: 1.5-2 mg/kg (peds: 6-7 mg/kg/24 h) IVPB q8h; follow levels
  • Imipenem-cilastatin: 500 mg (Peds 60-100 mg/kg/24 h) q6h
  • Levaquin: 500 mg IVPB q24h; contraindicated in peds
  • Hydromorphone: 0.5-2 mg IV (0.01-0.02 mg/kg), titrated to pain relief.
  • Metronidazole: 500 mg (peds: 30 mg/kg/24 h) IVPB q6h
  • Piperacillin/tazobactam: 3.375 mg (peds: 300 mg/kg/24 h) IVPB q6h
  • Ondansetron: 4-8 mg IV, (0.15-0.3 mg/kg) IV (not to exceed 8 mg/dose IV), q4h PRN vomiting

Follow-Up


Disposition


Admission Criteria
  • All patients with acute cholangitis should be admitted with immediate surgical and gastroenterologic consultation.
  • Admit patients with signs of septic shock to the ICU.

Discharge Criteria
None  
Issues for Referral
Surgery/GI consultation  

Followup Recommendations


Admission to hospital for IV antibiotic and possible biliary drainage procedure.  

Pearls and Pitfalls


  • Aggressively fluid resuscitate patients.
  • Administer antibiotics.
  • Obtain GI and surgical consultations.

Additional Reading


  • Jackson  PG, Evans  SR. Biliary system. In: Townsend  CM Jr, ed. Sabiston Textbook of Surgery. 19th ed. Philadelphia, PA: WB Saunders; 2012:1476-1514.
  • Kinney  TP. Management of ascending cholangitis. Gastrointest Endosc Clin N Am.  2007;17:289-306.
  • Silen  W. Cholecystitis and other causes of acute pain in the right upper quadrant of the abdomen. In: Silen  W, ed. Copes Early Diagnosis of the Acute Abdomen. 22nd ed. Oxford, UK: Oxford University Press; 2010:131-141.
  • Solomkin  JS, Mazuski  JE, Baron  EJ, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis.  2010;50:997; 133-164.
  • Yusuf  TE, Baron  TH, AIDS Cholangiopathy. Curr Treat Options Gastroenterol.  2004;7:111-117.

See Also (Topic, Algorithm, Electronic Media Element)


  • Cholecystitis
  • Cholelithiasis

Codes


ICD9


576.1 Cholangitis  

ICD10


K83.0 Cholangitis  

SNOMED


  • 82403002 Cholangitis (disorder)
  • 235917005 Sclerosing cholangitis (disorder)
  • 281388009 Human immunodeficiency virus HIV-related sclerosing cholangitis (disorder)
  • 26918003 Ascending cholangitis (disorder)
  • 6215006 Acute cholangitis
Copyright © 2016 - 2017
Doctor123.org | Disclaimer